FSD Pharma Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.9544 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
189.74 | 4.83 | 3829.97% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-140.1 | -22.17 | 531.97% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-220.16 | 68.76 | -420.18% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | -17708.59 | -100% |
| ROE |
|
-140.97 | 9.61 | -1566.71% |
|
|
| ROA |
|
-106.78 | 0.3443 | -31118.58% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-155.17 | 15.45 | -1104.38% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0194 | -3.68 | -99.47% | -0.02 | -2.96% |
| Nеt Debt/Ebitda |
|
0.1384 | -3.44 | -104.03% |
|
|
| Debt/Ratio |
|
0.0194 | 0.1986 | -90.23% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.0182 | 10.32 | -100.18% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-98.84 | -57.64 | 71.48% | ||
| Growth impulse Ebitda in 5 years |
|
-31.32 | -90.94 | -65.56% | ||
| Growth impulse Net Income in 5 years |
|
-53.7 | -97.8 | -45.09% | ||
| Growth impulse FCF in 5 years |
|
-24.78 | -108.72 | -77.21% | ||
| Growth impulse EPS in 5 years |
|
-91.74 | -142.05 | -35.42% |
IP Score
2.08/10
